EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 46 / No 2 (June 2014) J Extra Corpor Technol, 46 2 (2014) 170-172 References
Free Access
Issue
J Extra Corpor Technol
Volume 46, Number 2, June 2014
Page(s) 170 - 172
DOI https://doi.org/10.1051/ject/201446170
Published online 15 June 2014
  1. Koster A, Buz S, Krabatsch T, Yeter R, Hetzer R. Bivalirudin anticoagulation during cardiac surgery: A single-center experience in 141 patients. Perfusion. 2009;24:7–11. [CrossRef] [PubMed] [Google Scholar]
  2. Gates R, Yost P, Parker B. The use of bivalirudin for cardiopulmonary bypass anticoagulation in pediatric heparin-induced thrombocytopenia patients. Artif Organs. 2010;34:667–669. [Google Scholar]
  3. Dragomer D, Chalfant A, Biniwale R, Reemtsen B, Federman M. Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia. Perfusion. 2011;26:516–518. [CrossRef] [PubMed] [Google Scholar]
  4. Dyke CM, Smedira NG, Koster A, et al. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The Evolution-On Study. J Thorac Cardiovasc Surg. 2006;131:533–539. [CrossRef] [Google Scholar]
  5. Morshuis M, Boergermann J, Gummert J, Koster A. A modified technique for the implantation of the HeartWare left ventricular assist device when using bivalirudin anticoagulation in patient with acute heparin-induced thrombocytopenia. Interact Cardiovasc Thorac Surg. 2013;17:225–226. [CrossRef] [PubMed] [Google Scholar]
  6. Crouch MA, Kasirajan V, Cahoon W, Katlaps GJ, Gunnerson KJ. Successful use and dosing of bivalirudin after temporary total artificial heart implantation: A case series. Pharmacotherapy. 2008;28:1413–1420. [CrossRef] [PubMed] [Google Scholar]
  7. Ensor CR, Cahoon WD, Crouch MA, et al. Antithrombotic therapy for the CardioWest temporary total artificial heart. Tex Heart Inst J. 2010;37:149–158. [Google Scholar]
  8. Schenk S, El-Banayosy A, Prohaska W, et al. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support. J Thorac Cardiovasc Surg. 2006;131:1373–1381. [CrossRef] [Google Scholar]
  9. Koster A, Huebler S, Potapov E, Groman T, Kuppe H, Hetzer H. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: A single center experience in 358 consecutive patients. Ann Thorac Surg. 2007;83:72–76. [CrossRef] [Google Scholar]
  10. Linkins ,LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th edition). Chest. 2012;141 (Suppl):e495S–530S. [CrossRef] [Google Scholar]
  11. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg. 2003;76:2121–2131. [CrossRef] [Google Scholar]
  12. Koster A, Chew D, Grundel M, Bauer M, Kuppe H, Spiess BD. Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesth Analg. 2003;96:383–386. [Google Scholar]
  13. Gallandat Huet RC, Cernak V, de Vries AJ, Lisman T. Bivalirudin is inferior to heparin in preservation of intraoperative autologous blood. Thromb Res. 2012;130:163–165. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.